Developing retinal biomarkers of neurological disease: an analytical perspective

被引:3
|
作者
MacCormick, Ian J. C. [1 ,2 ,3 ]
Czanner, Gabriela [1 ,4 ]
Faragher, Brian [5 ]
机构
[1] Univ Liverpool, Dept Eye & Vis Sci, Liverpool L69 3BX, Merseyside, England
[2] Malawi Liverpool Wellcome Trust, Clin Res Programme, Blantyre, Malawi
[3] Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh, Midlothian, Scotland
[4] Univ Liverpool, Dept Biostat, Liverpool L69 3BX, Merseyside, England
[5] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England
基金
英国惠康基金;
关键词
biomarker; brain; cerebral malaria; proxy marker; retina; surrogate end point; SURROGATE END-POINTS; CEREBRAL MALARIA; CLINICAL-TRIALS; CHILDREN; VALIDATION; BRAIN;
D O I
10.2217/BMM.15.17
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The inaccessibility of the brain poses a problem for neuroscience. Scientists have traditionally responded by developing biomarkers for brain physiology and disease. The retina is an attractive source of biomarkers since it shares many features with the brain. Some even describe the retina as a 'window' to the brain, implying that retinal signs are analogous to brain disease features. However, new analytical methods are needed to show whether or not retinal signs really are equivalent to brain abnormalities, since this requires greater evidence than direct associations between retina and brain. We, therefore propose a new way to think about, and test, how clearly one might see the brain through the retinal window, using cerebral malaria as a case study.
引用
收藏
页码:691 / 701
页数:11
相关论文
共 50 条
  • [1] Developing retinal biomarkers of neurological disease: an analytical perspective (vol 9, pg 691, 2015)
    MacCormick, Ian J. C.
    Czanner, Gabriela
    Faragher, Brian
    BIOMARKERS IN MEDICINE, 2015, 9 (09) : 937 - 937
  • [2] PERSPECTIVE Retinal Biomarkers of Alzheimer Disease
    Lee, Cecilia S.
    Apte, Rajendra S.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2020, 218 : 337 - 341
  • [3] Design strategies, current applications and future perspective of aptasensors for neurological disease biomarkers
    Erkmen, Cem
    Tig, Gozde Aydogdu
    Marrazza, Giovanna
    Uslu, Bengi
    TRAC-TRENDS IN ANALYTICAL CHEMISTRY, 2022, 154
  • [4] BIOMARKERS IN NEUROLOGICAL DISEASE - SNAPSHOT
    Gajdosik, Z.
    DRUGS OF THE FUTURE, 2013, 38 (02) : 115 - 122
  • [5] Developing Neuroimaging Biomarkers for Depression Secondary to Neurological Illnesses
    Kvarta, Mark
    Ma, Yizhou
    Gao, Si
    Bruce, Heather
    Chiappelli, Joshua
    Kochunov, Peter
    Hong, Elliot
    NEUROPSYCHOPHARMACOLOGY, 2022, 47 (SUPPL 1) : 274 - 274
  • [6] Developing Neuroimaging Biomarkers for Depression Secondary to Neurological Illnesses
    Kvarta, Mark
    Ma, Yizhou
    Gao, Si
    Bruce, Heather
    Chiappelli, Joshua
    Kochunov, Peter
    Hong, Elliot
    NEUROPSYCHOPHARMACOLOGY, 2022, 47 : 274 - 274
  • [7] Biomarkers of alzheimer disease and neurological disorders
    Abdelwareth, L.
    CLINICA CHIMICA ACTA, 2024, 558
  • [8] Discovery and development of biomarkers of neurological disease
    Dunckley, T
    Coon, KD
    Stephan, DA
    DRUG DISCOVERY TODAY, 2005, 10 (05) : 326 - 334
  • [9] A neurological perspective on mitochondrial disease
    McFarland, Robert
    Taylor, Robert W.
    Turnbull, Douglass M.
    LANCET NEUROLOGY, 2010, 9 (08): : 829 - 840
  • [10] Biomarkers in the diagnosis of wounds infection: An analytical perspective
    Mota, Fatima A. R.
    Pereira, Sarah A. P.
    Araujo, Andre R. T. S.
    Passos, Marieta L. C.
    Saraiva, M. Lucia M. F. S.
    TRAC-TRENDS IN ANALYTICAL CHEMISTRY, 2021, 143